CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Research and development, 2025
- $255M
- YoY, 2025
- +3.2%
- 5-year CAGR
- +17.3%
- 10-year CAGR
- +32.4%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $255M | +3.2% |
| 2024 | $247M | +33.9% |
| 2023 | $184M | +40.7% |
| 2022 | $131M | +15.0% |
| 2021 | $114M | −0.8% |
| 2020 | $115M | +28.9% |
| 2019 | $89M | +18.3% |
| 2018 | $75M | +86.4% |
| 2017 | $40M | +69.3% |
| 2016 | $24M | +54.6% |
| 2015 | $15M | −16.1% |
| 2014 | $18M | −10.2% |
| 2013 | $20M | +45.4% |
| 2012 | $14M | −33.0% |
| 2011 | $21M | +10.8% |
| 2010 | $19M | +31.6% |
| 2009 | $14M | — |